Literature DB >> 19014385

Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells.

Jaya Prasanthi Rantham Prabhakara1, Gwen Feist, Sarah Thomasson, Alex Thompson, Eric Schommer, Othman Ghribi.   

Abstract

Evidence suggests that environmental and dietary factors may contribute to the pathogenesis of Parkinson's disease (PD). High dietary intake of cholesterol is such a factor that has been shown to increase or decrease the risk of PD. However, because circulating cholesterol does not cross the blood-brain barrier, the mechanisms linking dietary cholesterol to the pathogenesis of PD remain to be understood. In contrast to cholesterol, the oxidized cholesterol metabolites (oxysterols), 24S-hydroxycholesterol (24-OHC) and 27-hydroxycholesterol (27-OHC), can cross the blood-brain barrier and may place the brain at risk of degeneration. In this study, we incubated the human neuroblastoma SH-SY5Y cells for 24 h with 24-OHC, 27-OHC, or a mixture of 24-OHC plus 27-OHC, and have determined effects on tyrosine hydroxylase (the rate-limiting enzyme in dopamine synthesis) levels, alpha-synuclein levels, and apoptosis. We demonstrate that while 24-OHC increases the levels of tyrosine hydroxylase, 27-OHC increases levels of alpha-synuclein, and induces apoptosis. Our findings show for the first time that oxysterols trigger changes in levels of proteins that are associated with the pathogenesis of PD. As steady state levels of 24-OHC and 27-OHC are tightly regulated in the brain, disturbances in these levels may contribute to the pathogenesis of PD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19014385      PMCID: PMC3205449          DOI: 10.1111/j.1471-4159.2008.05736.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  101 in total

1.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

2.  An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha.

Authors:  B A Janowski; P J Willy; T R Devi; J R Falck; D J Mangelsdorf
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

3.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

Review 4.  Steroid hormone receptors: many actors in search of a plot.

Authors:  M Beato; P Herrlich; G Schütz
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

5.  DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity.

Authors:  Wenbo Zhou; Curt R Freed
Journal:  J Biol Chem       Date:  2005-10-14       Impact factor: 5.157

6.  Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells.

Authors:  Xiangmin Peng; Xiangmin M Peng; Roya Tehranian; Paula Dietrich; Leonidas Stefanis; Ruth G Perez
Journal:  J Cell Sci       Date:  2005-07-19       Impact factor: 5.285

7.  Effect of alpha-synuclein on the promoter activity of tyrosine hydroxylase gene.

Authors:  Nan Gao; Yao-Hua Li; Xin Li; Shun Yu; Gui-Lian Fu; Biao Chen
Journal:  Neurosci Bull       Date:  2007-01       Impact factor: 5.203

8.  Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications.

Authors:  Matt Farrer; Jennifer Kachergus; Lysia Forno; Sarah Lincoln; Deng-Shun Wang; Mary Hulihan; Demetrius Maraganore; Katrina Gwinn-Hardy; Zbigniew Wszolek; Dennis Dickson; J William Langston
Journal:  Ann Neurol       Date:  2004-02       Impact factor: 10.422

9.  Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells.

Authors:  Shun Yu; Xiaohong Zuo; Yaohua Li; Chen Zhang; Ming Zhou; Yu Alex Zhang; Kenji Uéda; Piu Chan
Journal:  Neurosci Lett       Date:  2004-08-26       Impact factor: 3.046

10.  Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha.

Authors:  D J Peet; S D Turley; W Ma; B A Janowski; J M Lobaccaro; R E Hammer; D J Mangelsdorf
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

View more
  34 in total

1.  The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease.

Authors:  Gurdeep Marwarha; Turk Rhen; Trevor Schommer; Othman Ghribi
Journal:  J Neurochem       Date:  2011-10-24       Impact factor: 5.372

2.  Association between Cholesterol Exposure and Neuropathological Findings: The ACT Study.

Authors:  Brianne M Bettcher; M Colin Ard; Bruce R Reed; Andreana Benitez; Amanda Simmons; Eric B Larson; Josh A Sonnen; Thomas J Montine; Ge Li; C Dirk Keene; Paul K Crane; Dan Mungas
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 3.  LXR agonists: new potential therapeutic drug for neurodegenerative diseases.

Authors:  Pei Xu; Dabing Li; Xiaotong Tang; Xiaohang Bao; Jing Huang; Yongping Tang; Yang Yang; Haiwei Xu; Xiaotang Fan
Journal:  Mol Neurobiol       Date:  2013-04-27       Impact factor: 5.590

Review 4.  Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap?

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Exp Gerontol       Date:  2014-09-28       Impact factor: 4.032

5.  Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.

Authors:  Ludger Schöls; Tim W Rattay; Peter Martus; Christoph Meisner; Jonathan Baets; Imma Fischer; Christine Jägle; Matthew J Fraidakis; Andrea Martinuzzi; Jonas Alex Saute; Marina Scarlato; Antonella Antenora; Claudia Stendel; Philip Höflinger; Charles Marques Lourenco; Lisa Abreu; Katrien Smets; Martin Paucar; Tine Deconinck; Dana M Bis; Sarah Wiethoff; Peter Bauer; Alessia Arnoldi; Wilson Marques; Laura Bannach Jardim; Stefan Hauser; Chiara Criscuolo; Alessandro Filla; Stephan Züchner; Maria Teresa Bassi; Thomas Klopstock; Peter De Jonghe; Ingemar Björkhem; Rebecca Schüle
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

6.  Liver X receptor β protects dopaminergic neurons in a mouse model of Parkinson disease.

Authors:  Yu-bing Dai; Xin-jie Tan; Wan-fu Wu; Margaret Warner; Jan-Åke Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

7.  The oxysterol 27-hydroxycholesterol increases β-amyloid and oxidative stress in retinal pigment epithelial cells.

Authors:  Bhanu Dasari; Jaya R P Prasanthi; Gurdeep Marwarha; Brij B Singh; Othman Ghribi
Journal:  BMC Ophthalmol       Date:  2010-09-13       Impact factor: 2.209

8.  Plasma apolipoprotein A1 as a biomarker for Parkinson disease.

Authors:  Judy K Qiang; Yvette C Wong; Andrew Siderowf; Howard I Hurtig; Sharon X Xie; Virginia M-Y Lee; John Q Trojanowski; Dora Yearout; James B Leverenz; Thomas J Montine; Matt Stern; Susan Mendick; Danna Jennings; Cyrus Zabetian; Ken Marek; Alice S Chen-Plotkin
Journal:  Ann Neurol       Date:  2013-08-06       Impact factor: 10.422

9.  Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies.

Authors:  Andrew O Koob; Kiren Ubhi; Johan F Paulsson; Jeffery Kelly; Edward Rockenstein; Michael Mante; Anthony Adame; Eliezer Masliah
Journal:  Exp Neurol       Date:  2009-11-26       Impact factor: 5.330

10.  Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells.

Authors:  Jaya Prasanthi Rantham Prabhakara; Gwen Feist; Sarah Thomasson; Alex Thompson; Eric Schommer; Othman Ghribi
Journal:  J Neurochem       Date:  2008-11-05       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.